Pig
Azaperone
Tissue
MRL
Year of Adoption
Note
Fat
60 µg/kg
1999
None
Tissue
Fat
MRL
60 µg/kg
Year of Adoption
1999
Note
None
Kidney
100 µg/kg
1999
None
Tissue
Kidney
MRL
100 µg/kg
Year of Adoption
1999
Note
None
Liver
100 µg/kg
1999
None
Tissue
Liver
MRL
100 µg/kg
Year of Adoption
1999
Note
None
Muscle
60 µg/kg
1999
None
Tissue
Muscle
MRL
60 µg/kg
Year of Adoption
1999
Note
None
Showing 1 to 4 of 4 entries
Benzylpenicillin/Procaine benzylpenicillin
Tissue
MRL
Year of Adoption
Note
Kidney
50 µg/kg
1999
None
Tissue
Kidney
MRL
50 µg/kg
Year of Adoption
1999
Note
None
Liver
50 µg/kg
1999
None
Tissue
Liver
MRL
50 µg/kg
Year of Adoption
1999
Note
None
Muscle
50 µg/kg
1999
None
Tissue
Muscle
MRL
50 µg/kg
Year of Adoption
1999
Note
None
Showing 1 to 3 of 3 entries
Carazolol
Tissue
MRL
Year of Adoption
Note
Fat/Skin
5 µg/kg
2003
The concentration at the injection site two hours after treatment may result in an intake that exceeds the acute RfD and therefore, an appropriate withdrawal period should be applied.
Tissue
Fat/Skin
MRL
5 µg/kg
Year of Adoption
2003
Note
The concentration at the injection site two hours after treatment may result in an intake that exceeds the acute RfD and therefore, an appropriate withdrawal period should be applied.
Kidney
25 µg/kg
2003
None
Tissue
Kidney
MRL
25 µg/kg
Year of Adoption
2003
Note
None
Liver
25 µg/kg
2003
None
Tissue
Liver
MRL
25 µg/kg
Year of Adoption
2003
Note
None
Muscle
5 µg/kg
2003
The concentration at the injection site two hours after treatment may result in an intake that exceeds the acute RfD and therefore, an appropriate withdrawal period should be applied.
Tissue
Muscle
MRL
5 µg/kg
Year of Adoption
2003
Note
The concentration at the injection site two hours after treatment may result in an intake that exceeds the acute RfD and therefore, an appropriate withdrawal period should be applied.
Showing 1 to 4 of 4 entries
Ceftiofur
Tissue
MRL
Year of Adoption
Note
Fat
2000 µg/kg
1999
None
Tissue
Fat
MRL
2000 µg/kg
Year of Adoption
1999
Note
None
Kidney
6000 µg/kg
1999
None
Tissue
Kidney
MRL
6000 µg/kg
Year of Adoption
1999
Note
None
Liver
2000 µg/kg
1999
None
Tissue
Liver
MRL
2000 µg/kg
Year of Adoption
1999
Note
None
Muscle
1000 µg/kg
1999
None
Tissue
Muscle
MRL
1000 µg/kg
Year of Adoption
1999
Note
None
Showing 1 to 4 of 4 entries
Chlortetracycline/Oxytetracycline/Tetracycline
Tissue
MRL
Year of Adoption
Note
Kidney
1200 µg/kg
2003
None
Tissue
Kidney
MRL
1200 µg/kg
Year of Adoption
2003
Note
None
Liver
600 µg/kg
2003
None
Tissue
Liver
MRL
600 µg/kg
Year of Adoption
2003
Note
None
Muscle
200 µg/kg
2003
None
Tissue
Muscle
MRL
200 µg/kg
Year of Adoption
2003
Note
None
Showing 1 to 3 of 3 entries
Cyhalothrin
Tissue
MRL
Year of Adoption
Note
Fat
400 µg/kg
2005
None
Tissue
Fat
MRL
400 µg/kg
Year of Adoption
2005
Note
None
Kidney
20 µg/kg
2005
None
Tissue
Kidney
MRL
20 µg/kg
Year of Adoption
2005
Note
None
Liver
20 µg/kg
2005
None
Tissue
Liver
MRL
20 µg/kg
Year of Adoption
2005
Note
None
Muscle
20 µg/kg
2005
None
Tissue
Muscle
MRL
20 µg/kg
Year of Adoption
2005
Note
None
Showing 1 to 4 of 4 entries
Danofloxacin
Tissue
MRL
Year of Adoption
Note
Fat
100 µg/kg
2001
None
Tissue
Fat
MRL
100 µg/kg
Year of Adoption
2001
Note
None
Kidney
200 µg/kg
2001
None
Tissue
Kidney
MRL
200 µg/kg
Year of Adoption
2001
Note
None
Liver
50 µg/kg
2001
None
Tissue
Liver
MRL
50 µg/kg
Year of Adoption
2001
Note
None
Muscle
100 µg/kg
2001
None
Tissue
Muscle
MRL
100 µg/kg
Year of Adoption
2001
Note
None
Showing 1 to 4 of 4 entries
Dexamethasone
Tissue
MRL
Year of Adoption
Note
Kidney
1.0 µg/kg
2009
None
Tissue
Kidney
MRL
1.0 µg/kg
Year of Adoption
2009
Note
None
Liver
2.0 µg/kg
2009
None
Tissue
Liver
MRL
2.0 µg/kg
Year of Adoption
2009
Note
None
Muscle
1.0 µg/kg
2009
None
Tissue
Muscle
MRL
1.0 µg/kg
Year of Adoption
2009
Note
None
Showing 1 to 3 of 3 entries
Dihydrostreptomycin/Streptomycin
Tissue
MRL
Year of Adoption
Note
Fat
600 µg/kg
2001
None
Tissue
Fat
MRL
600 µg/kg
Year of Adoption
2001
Note
None
Kidney
1000 µg/kg
2001
None
Tissue
Kidney
MRL
1000 µg/kg
Year of Adoption
2001
Note
None
Liver
600 µg/kg
2001
None
Tissue
Liver
MRL
600 µg/kg
Year of Adoption
2001
Note
None
Muscle
600 µg/kg
2001
None
Tissue
Muscle
MRL
600 µg/kg
Year of Adoption
2001
Note
None
Showing 1 to 4 of 4 entries
Doramectin
Tissue
MRL
Year of Adoption
Note
Fat
150 µg/kg
2001
None
Tissue
Fat
MRL
150 µg/kg
Year of Adoption
2001
Note
None
Kidney
30 µg/kg
2001
None
Tissue
Kidney
MRL
30 µg/kg
Year of Adoption
2001
Note
None
Liver
100 µg/kg
2001
None
Tissue
Liver
MRL
100 µg/kg
Year of Adoption
2001
Note
None
Muscle
5 µg/kg
2001
None
Tissue
Muscle
MRL
5 µg/kg
Year of Adoption
2001
Note
None
Showing 1 to 4 of 4 entries
Febantel/Fenbendazole/Oxfendazole
Tissue
MRL
Year of Adoption
Note
Fat
100 µg/kg
1999
None
Tissue
Fat
MRL
100 µg/kg
Year of Adoption
1999
Note
None
Kidney
100 µg/kg
1999
None
Tissue
Kidney
MRL
100 µg/kg
Year of Adoption
1999
Note
None
Liver
500 µg/kg
1999
None
Tissue
Liver
MRL
500 µg/kg
Year of Adoption
1999
Note
None
Muscle
100 µg/kg
1999
None
Tissue
Muscle
MRL
100 µg/kg
Year of Adoption
1999
Note
None
Showing 1 to 4 of 4 entries
Flubendazole
Tissue
MRL
Year of Adoption
Note
Liver
10 µg/kg
1995
None
Tissue
Liver
MRL
10 µg/kg
Year of Adoption
1995
Note
None
Muscle
10 µg/kg
1995
None
Tissue
Muscle
MRL
10 µg/kg
Year of Adoption
1995
Note
None
Showing 1 to 2 of 2 entries
Flumequine
Tissue
MRL
Year of Adoption
Note
Fat
1000 µg/kg
2005
None
Tissue
Fat
MRL
1000 µg/kg
Year of Adoption
2005
Note
None
Kidney
3000 µg/kg
2005
None
Tissue
Kidney
MRL
3000 µg/kg
Year of Adoption
2005
Note
None
Liver
500 µg/kg
2005
None
Tissue
Liver
MRL
500 µg/kg
Year of Adoption
2005
Note
None
Muscle
500 µg/kg
2005
None
Tissue
Muscle
MRL
500 µg/kg
Year of Adoption
2005
Note
None
Showing 1 to 4 of 4 entries
Gentamicin
Tissue
MRL
Year of Adoption
Note
Fat
100 µg/kg
2001
None
Tissue
Fat
MRL
100 µg/kg
Year of Adoption
2001
Note
None
Kidney
5000 µg/kg
2001
None
Tissue
Kidney
MRL
5000 µg/kg
Year of Adoption
2001
Note
None
Liver
2000 µg/kg
2001
None
Tissue
Liver
MRL
2000 µg/kg
Year of Adoption
2001
Note
None
Muscle
100 µg/kg
2001
None
Tissue
Muscle
MRL
100 µg/kg
Year of Adoption
2001
Note
None
Showing 1 to 4 of 4 entries
Ivermectin
Tissue
MRL
Year of Adoption
Note
Fat
20 µg/kg
1993
None
Tissue
Fat
MRL
20 µg/kg
Year of Adoption
1993
Note
None
Liver
15 µg/kg
1993
None
Tissue
Liver
MRL
15 µg/kg
Year of Adoption
1993
Note
None
Showing 1 to 2 of 2 entries
Levamisole
Tissue
MRL
Year of Adoption
Note
Fat
10 µg/kg
1997
None
Tissue
Fat
MRL
10 µg/kg
Year of Adoption
1997
Note
None
Kidney
10 µg/kg
1997
None
Tissue
Kidney
MRL
10 µg/kg
Year of Adoption
1997
Note
None
Liver
100 µg/kg
1997
None
Tissue
Liver
MRL
100 µg/kg
Year of Adoption
1997
Note
None
Muscle
10 µg/kg
1997
None
Tissue
Muscle
MRL
10 µg/kg
Year of Adoption
1997
Note
None
Showing 1 to 4 of 4 entries
Lincomycin
Tissue
MRL
Year of Adoption
Note
Fat
100 µg/kg
2003
Additional MRL for skin with adhering fat of 300 µg/Kg.
Tissue
Fat
MRL
100 µg/kg
Year of Adoption
2003
Note
Additional MRL for skin with adhering fat of 300 µg/Kg.
Kidney
1500 µg/kg
2003
None
Tissue
Kidney
MRL
1500 µg/kg
Year of Adoption
2003
Note
None
Liver
500 µg/kg
2003
None
Tissue
Liver
MRL
500 µg/kg
Year of Adoption
2003
Note
None
Muscle
200 µg/kg
2003
None
Tissue
Muscle
MRL
200 µg/kg
Year of Adoption
2003
Note
None
Showing 1 to 4 of 4 entries
Neomycin
Tissue
MRL
Year of Adoption
Note
Fat
500 µg/kg
1999
None
Tissue
Fat
MRL
500 µg/kg
Year of Adoption
1999
Note
None
Kidney
10000 µg/kg
1999
None
Tissue
Kidney
MRL
10000 µg/kg
Year of Adoption
1999
Note
None
Liver
500 µg/kg
1999
None
Tissue
Liver
MRL
500 µg/kg
Year of Adoption
1999
Note
None
Muscle
500 µg/kg
1999
None
Tissue
Muscle
MRL
500 µg/kg
Year of Adoption
1999
Note
None
Showing 1 to 4 of 4 entries
Phoxim
Tissue
MRL
Year of Adoption
Note
Fat
400 µg/kg
2003
None
Tissue
Fat
MRL
400 µg/kg
Year of Adoption
2003
Note
None
Kidney
50 µg/kg
2003
None
Tissue
Kidney
MRL
50 µg/kg
Year of Adoption
2003
Note
None
Liver
50 µg/kg
2003
None
Tissue
Liver
MRL
50 µg/kg
Year of Adoption
2003
Note
None
Muscle
50 µg/kg
2003
None
Tissue
Muscle
MRL
50 µg/kg
Year of Adoption
2003
Note
None
Showing 1 to 4 of 4 entries
Porcine somatotropin
Tissue
MRL
Year of Adoption
Note
Fat
not specified -
2003
None
Tissue
Fat
MRL
not specified -
Year of Adoption
2003
Note
None
Kidney
not specified -
2003
None
Tissue
Kidney
MRL
not specified -
Year of Adoption
2003
Note
None
Liver
not specified -
2003
None
Tissue
Liver
MRL
not specified -
Year of Adoption
2003
Note
None
Muscle
not specified -
2003
None
Tissue
Muscle
MRL
not specified -
Year of Adoption
2003
Note
None
Showing 1 to 4 of 4 entries
Spectinomycin
Tissue
MRL
Year of Adoption
Note
Fat
2000 µg/kg
1999
None
Tissue
Fat
MRL
2000 µg/kg
Year of Adoption
1999
Note
None
Kidney
5000 µg/kg
1999
None
Tissue
Kidney
MRL
5000 µg/kg
Year of Adoption
1999
Note
None
Liver
2000 µg/kg
1999
None
Tissue
Liver
MRL
2000 µg/kg
Year of Adoption
1999
Note
None
Muscle
500 µg/kg
1999
None
Tissue
Muscle
MRL
500 µg/kg
Year of Adoption
1999
Note
None
Showing 1 to 4 of 4 entries
Spiramycin
Tissue
MRL
Year of Adoption
Note
Fat
300 µg/kg
1997
None
Tissue
Fat
MRL
300 µg/kg
Year of Adoption
1997
Note
None
Kidney
300 µg/kg
1997
None
Tissue
Kidney
MRL
300 µg/kg
Year of Adoption
1997
Note
None
Liver
600 µg/kg
1997
None
Tissue
Liver
MRL
600 µg/kg
Year of Adoption
1997
Note
None
Muscle
200 µg/kg
1997
None
Tissue
Muscle
MRL
200 µg/kg
Year of Adoption
1997
Note
None
Showing 1 to 4 of 4 entries
Thiabendazole
Tissue
MRL
Year of Adoption
Note
Fat
100 µg/kg
1995
The MRL also covers residues derived from feed containing the residues resulted from agricultural use.
Tissue
Fat
MRL
100 µg/kg
Year of Adoption
1995
Note
The MRL also covers residues derived from feed containing the residues resulted from agricultural use.
Kidney
100 µg/kg
1995
The MRL also covers residues derived from feed containing the residues resulted from agricultural use.
Tissue
Kidney
MRL
100 µg/kg
Year of Adoption
1995
Note
The MRL also covers residues derived from feed containing the residues resulted from agricultural use.
Liver
100 µg/kg
1995
The MRL also covers residues derived from feed containing the residues resulted from agricultural use.
Tissue
Liver
MRL
100 µg/kg
Year of Adoption
1995
Note
The MRL also covers residues derived from feed containing the residues resulted from agricultural use.
Muscle
100 µg/kg
1995
The MRL also covers residues derived from feed containing the residues resulted from agricultural use.
Tissue
Muscle
MRL
100 µg/kg
Year of Adoption
1995
Note
The MRL also covers residues derived from feed containing the residues resulted from agricultural use.
Showing 1 to 4 of 4 entries
Tilmicosin
Tissue
MRL
Year of Adoption
Note
Fat
100 µg/kg
1999
None
Tissue
Fat
MRL
100 µg/kg
Year of Adoption
1999
Note
None
Kidney
1000 µg/kg
1999
None
Tissue
Kidney
MRL
1000 µg/kg
Year of Adoption
1999
Note
None
Liver
1500 µg/kg
1999
None
Tissue
Liver
MRL
1500 µg/kg
Year of Adoption
1999
Note
None
Muscle
100 µg/kg
1999
None
Tissue
Muscle
MRL
100 µg/kg
Year of Adoption
1999
Note
None